23

Listed companies

7

Private companies

22

Insiders

Relation chart of related listed companies: Abbisko Cayman Limited

Active Relations

Past Relations

Relationship chart for related private companies: Abbisko Cayman Limited

Active Relations

Past Relations

Related private companies: Abbisko Cayman Limited

The Chartered Governance Institute

Miscellaneous Commercial Services

The Hong Kong Institute of Chartered Secretaries

Miscellaneous Commercial Services

Qiming Venture Partners Ltd.

Investment Managers

Abbisko Therapeutics Co., Ltd.

Pharmaceuticals: Major

SWCS Corporate Services Group (Hong Kong) Ltd.

Miscellaneous Commercial Services

Wuxi Abbisko Biomedical Technology Co. Ltd.

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major7
Miscellaneous Commercial Services4
Packaged Software3
Biotechnology2
Medical/Nursing Services2
Medical Specialties2
Investment Managers1
Real Estate Development1
Beverages: Non-Alcoholic1
Food: Major Diversified1

Countries of related companies

China20
Hong Kong7
United Kingdom1
United States1
Singapore1
Logo Abbisko Cayman Limited
Abbisko Cayman Ltd is a clinical-stage biopharmaceutical company. The Company is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The Company owns two Core Product Candidates, ABSK011 and ABSK091, and 12 other pipeline product candidates. ABSK011 is a potent and highly selective small molecule inhibitor of fibroblast growth factor receptor 4 (FGFR4). ABSK091 is a molecularly targeted product candidate and a highly potent and selective inhibitor of FGFR subtypes 1, 2 and 3. The Company’s products are primarily being developed for hepatocellular carcinoma (HCC), urothelial cancer (UC) and gastric cancer (GC).
Employees
-